Display options
Share it on

Blood Res. 2019 Mar;54(1):31-37. doi: 10.5045/br.2019.54.1.31. Epub 2019 Mar 21.

Biochemical effects and safety of Gum arabic (.

Blood research

Lamis AbdelGadir Kaddam, Imad Fdl-Elmula, Omer Ali Eisawi, Haydar Awad Abdelrazig, Mustafa Khidir Elnimeiri, Amal Mahmoud Saeed

Affiliations

  1. Department of Physiology, Faculty of Medicine, Al Neelain University, Khartoum, Sudan.
  2. Department of Clinical Genetics, Faculty of Medicine, Al Neelain University, Khartoum, Sudan.
  3. Department of Hematology, Military Hospital Khartoum, Khartoum, Sudan.
  4. Department of Pediatrics, Military Hospital Khartoum, Khartoum, Sudan.
  5. Department of Community Medicine, Faculty of Medicine, Al Neelain University, Khartoum, Sudan.
  6. Department of Physiology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

PMID: 30956961 PMCID: PMC6439290 DOI: 10.5045/br.2019.54.1.31

Abstract

BACKGROUND: Sickle cell anemia (SCA) is a hereditary chronic hemolytic anemia with several clinical consequences. Intravascular sickling of red blood cells leads to multi-organ dysfunction. Moreover, several biochemical abnormalities have been associated with SCA. Gum arabic (GA) is an edible dried gummy exudate obtained from

METHODS: Forty-seven patients (5-42 yr) carrying hemoglobin SS were recruited. The patients received 30 g/day GA for 12 weeks. Blood samples were collected before administering GA and then after 4, 8, and 12 weeks. Liver enzymes, total protein, albumin, electrolytes, urea, creatinine, and uric acid were determined in the serum. The study was approved by the Al Neelain University Institutional Review Board and Research Ethics Committee Ministry of Health. The trial was registered at ClinicalTrials.gov (identifier: NCT02467257).

RESULTS: GA significantly decreased direct bilirubin level [statistical significance (

CONCLUSION: GA may alter the disease severity in SCA as demonstrated by its ability to decrease direct bilirubin and urea levels in the serum.

Keywords: Bilirubin; Gum arabic; Liver enzyme; Sickle cell anemia; Urea

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

References

  1. J Biochem Mol Toxicol. 2003;17(3):146-53 - PubMed
  2. Pharmacol Res. 2003 Dec;48(6):631-5 - PubMed
  3. Ann Hepatol. 2005 Oct-Dec;4(4):261-3 - PubMed
  4. Haematologica. 2006 Aug;91(8):1076-83 - PubMed
  5. Trop Gastroenterol. 2006 Jul-Sep;27(3):118-21 - PubMed
  6. Arch Intern Med. 2007 Apr 9;167(7):701-8 - PubMed
  7. J Trop Pediatr. 2007 Oct;53(5):362-5 - PubMed
  8. J Ren Nutr. 2008 Mar;18(2):230-8 - PubMed
  9. Bull World Health Organ. 2008 Jun;86(6):480-7 - PubMed
  10. Food Chem Toxicol. 2009 Jan;47(1):1-8 - PubMed
  11. Pediatr Nephrol. 2010 Oct;25(10):2123-7 - PubMed
  12. Kidney Blood Press Res. 2012;35(5):365-72 - PubMed
  13. Physiol Res. 2013;62(1):47-56 - PubMed
  14. PLoS One. 2013;8(2):e55242 - PubMed
  15. Niger Postgrad Med J. 2012 Dec;19(4):204-7 - PubMed
  16. Indian J Clin Biochem. 2012 Apr;27(2):191-5 - PubMed
  17. PLoS One. 2014 May 08;9(5):e96561 - PubMed
  18. BMC Hematol. 2015 Dec 29;15:19 - PubMed
  19. BMC Hematol. 2017 Mar 16;17:4 - PubMed
  20. JAMA. 1971 Jan 11;215(2):255-8 - PubMed
  21. J Clin Pathol. 1984 Sep;37(9):1046-9 - PubMed
  22. Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1181-3 - PubMed
  23. Am J Clin Nutr. 1983 Mar;37(3):368-75 - PubMed
  24. J Clin Pathol. 1981 Sep;34(9):965-9 - PubMed
  25. Ann Rheum Dis. 1980 Aug;39(4):392-5 - PubMed
  26. Clin Chem. 1995 Dec;41(12 Pt 1):1751-60 - PubMed
  27. J Clin Pathol. 1995 Jul;48(7):648-51 - PubMed
  28. Br J Haematol. 1997 Sep;98(3):627-31 - PubMed

Publication Types